ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.684,76
-0,05%
S&P 500
5.310,47
0,04%
US Dollar vs BRL
5,1097
0,10%
Bitcoin
69.802,76
-2,30%
Brent Oil
82,415
-1,33%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Sierra Oncology Inc (SRRA)

  7. Sierra Oncology Inc (SRRA) Notícias

SRRA

Sierra Oncology (SRRA)

Sierra Oncology Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SRRA
DataHoraFonteTítuloCódigoCompanhia
14/02/202317:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SRRASierra Oncology Inc
18/07/202217:05GlobeNewswire Inc.Codexis Announces CEO Transition Effective August 9, 2022NASDAQ:SRRASierra Oncology Inc
11/07/202217:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SRRASierra Oncology Inc
11/07/202217:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:SRRASierra Oncology Inc
01/07/202218:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SRRASierra Oncology Inc
01/07/202217:19Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SRRASierra Oncology Inc
01/07/202217:17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SRRASierra Oncology Inc
01/07/202217:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRRASierra Oncology Inc
01/07/202210:38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SRRASierra Oncology Inc
17/06/202208:00Business WireSierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug AdministrationNASDAQ:SRRASierra Oncology Inc
26/05/202218:00Business WireMomelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual MeetingNASDAQ:SRRASierra Oncology Inc
16/05/202217:16Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SRRASierra Oncology Inc
12/05/202211:00Business WireSierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 Data at European Hematology Association Annual MeetingNASDAQ:SRRASierra Oncology Inc
06/05/202208:00Business WireSierra Oncology Reports First Quarter 2022 ResultsNASDAQ:SRRASierra Oncology Inc
05/05/202217:05Business WireSierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:SRRASierra Oncology Inc
02/05/202217:57Business WireSIERRA ONCOLOGY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Sierra Oncology, Inc - SRRANASDAQ:SRRASierra Oncology Inc
22/04/202215:33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SRRASierra Oncology Inc
14/04/202208:26TipRanksWhy Did Sierra Oncology Skyrocket on Wednesday?NASDAQ:SRRASierra Oncology Inc
13/04/202218:17Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:SRRASierra Oncology Inc
13/04/202217:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SRRASierra Oncology Inc
13/04/202204:24Dow Jones NewsGlaxoSmithKline to Acquire Sierra Oncology for $1.9 Billion -- UpdateNASDAQ:SRRASierra Oncology Inc
13/04/202203:57Dow Jones NewsGlaxoSmithKline to Acquire Sierra Oncology for $1.9 BillionNASDAQ:SRRASierra Oncology Inc
13/04/202203:05Business WireGSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bnNASDAQ:SRRASierra Oncology Inc
14/03/202212:05TipRanksAnalysts Offer Insights on Healthcare Companies: Sierra Oncology (SRRA) and DarioHealth (DRIO)NASDAQ:SRRASierra Oncology Inc
11/03/202209:00Business WireSierra Oncology to Participate in the Oppenheimer 32nd Annual Healthcare ConferenceNASDAQ:SRRASierra Oncology Inc
10/03/202213:05TipRanksAnalysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV) and Sierra Oncology (SRRA)NASDAQ:SRRASierra Oncology Inc
10/03/202209:46Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SRRASierra Oncology Inc
10/03/202209:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SRRASierra Oncology Inc
10/03/202209:00Business WireSierra Oncology Reports 2021 Year End ResultsNASDAQ:SRRASierra Oncology Inc
03/02/202218:05Business WireSierra Oncology Announces Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:SRRASierra Oncology Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SRRA

Seu Histórico Recente

NASDAQ
CATT
Catapult Communicatons
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados